39123-82-5,MFCD00512771
Catalog No.:AA00C8X7

39123-82-5 | N-1,3-Benzoxazol-2-ylguanidine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
95%+
2 weeks  
$358.00   $250.00
- +
5mg
95%+
2 weeks  
$398.00   $278.00
- +
10mg
95%+
2 weeks  
$426.00   $298.00
- +
25mg
95%+
2 weeks  
$529.00   $370.00
- +
500mg
>95%
2 weeks  
$592.00   $415.00
- +
1g
>95%
2 weeks  
$633.00   $443.00
- +
5g
>95%
2 weeks  
$1,143.00   $800.00
- +
10g
>95%
2 weeks  
$1,654.00   $1,158.00
- +
25g
>95%
2 weeks  
$2,725.00   $1,908.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00C8X7
Chemical Name:
N-1,3-Benzoxazol-2-ylguanidine
CAS Number:
39123-82-5
Molecular Formula:
C8H8N4O
Molecular Weight:
176.1753
MDL Number:
MFCD00512771
SMILES:
NC(=N)Nc1nc2c(o1)cccc2
NSC Number:
8967
Properties
Computed Properties
 
Complexity:
214  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
13  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
1  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
0.7  

Downstream Synthesis Route
39123-82-5    42466-67-1   
2-(Benzoxazol-2-ylamino)-5-cyano-3H-4-oxopyrimidine 

[1]ScientiaPharmaceutica,2003,vol.71,p.57-74

39123-82-5    3920-50-1    504-02-9   
C18H16N6O2 

[1]BioorganicandMedicinalChemistryLetters,2015,vol.25,p.721-727

[1]BioorganicandMedicinalChemistryLetters,2015,vol.25,p.721-727

[1]BioorganicandMedicinalChemistryLetters,2015,vol.25,p.721-727

[1]BioorganicandMedicinalChemistryLetters,2015,vol.25,p.721-727

Literature

Title: 2-(1,3-Benzoxazol-2-yl)guanidinium chloride.

Journal: Acta crystallographica. Section E, Structure reports online 20111101

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:39123-82-5 Molecular Formula|39123-82-5 MDL|39123-82-5 SMILES|39123-82-5 N-1,3-Benzoxazol-2-ylguanidine
Catalog No.: AA00C8X7
39123-82-5,MFCD00512771
39123-82-5 | N-1,3-Benzoxazol-2-ylguanidine
Pack Size: 1mg
Purity: 95%+
2 weeks
$358.00 $250.00
Pack Size: 5mg
Purity: 95%+
2 weeks
$398.00 $278.00
Pack Size: 10mg
Purity: 95%+
2 weeks
$426.00 $298.00
Pack Size: 25mg
Purity: 95%+
2 weeks
$529.00 $370.00
Pack Size: 500mg
Purity: >95%
2 weeks
$592.00 $415.00
Pack Size: 1g
Purity: >95%
2 weeks
$633.00 $443.00
Pack Size: 5g
Purity: >95%
2 weeks
$1,143.00 $800.00
Pack Size: 10g
Purity: >95%
2 weeks
$1,654.00 $1,158.00
Pack Size: 25g
Purity: >95%
2 weeks
$2,725.00 $1,908.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00C8X7
Chemical Name: N-1,3-Benzoxazol-2-ylguanidine
CAS Number: 39123-82-5
Molecular Formula: C8H8N4O
Molecular Weight: 176.1753
MDL Number: MFCD00512771
SMILES: NC(=N)Nc1nc2c(o1)cccc2
NSC Number: 8967
Properties
Complexity: 214  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 13  
Hydrogen Bond Acceptor Count: 3  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 1  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 0.7  
Downstream Synthesis Route
39123-82-5    42466-67-1   
2-(Benzoxazol-2-ylamino)-5-cyano-3H-4-oxopyrimidine 

[1]ScientiaPharmaceutica,2003,vol.71,p.57-74

39123-82-5    3920-50-1    504-02-9   
C18H16N6O2 

[1]BioorganicandMedicinalChemistryLetters,2015,vol.25,p.721-727

72990-37-5    39123-82-5    504-02-9    1428529-32-1 

[1]BioorganicandMedicinalChemistryLetters,2015,vol.25,p.721-727

39123-82-5    504-02-9    405174-97-2    1428529-50-3 

[1]BioorganicandMedicinalChemistryLetters,2015,vol.25,p.721-727

39123-82-5    1083197-78-7    504-02-9    1428529-36-5 

[1]BioorganicandMedicinalChemistryLetters,2015,vol.25,p.721-727

Literature fold

Title: 2-(1,3-Benzoxazol-2-yl)guanidinium chloride.

Journal: Acta crystallographica. Section E, Structure reports online20111101

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters20101101

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology20060501

Building Blocks More >
3482-38-0
3482-38-0
11-Keto fuidic Acid
AA00C92I
356048-02-7
356048-02-7
(4S)-4-Methyl-2-oxo-[1,3,2]dioxathiolane-4-carboxylic Acid Methyl Ester
AA00C993 | MFCD09840994
318290-98-1
318290-98-1
5-Chloro-2-((3,4,4-trifluorobut-3-en-1-yl)sulfonyl)thiazole
AA00C9G0 | MFCD29047086
34571-16-9
34571-16-9
1,2,3,4,7,7-hexachloro-5-(tetrabromophenyl)bicyclo[2.2.1]hept-2-ene
AA00C9MR | MFCD27665443
31366-07-1
31366-07-1
3,3-Dimethylbutyrophenone
AA00C9SR | MFCD03841073
34604-52-9
34604-52-9
Diethylene glycol dimethanesulfonate
AA00C9YW | MFCD01730454
354153-65-4
354153-65-4
(S)-2-Amino-2-(4-bromophenyl)ethanol
AA00CA9Q | MFCD09256372
31555-60-9
31555-60-9
5-bromothiophene-2-carbonyl chloride
AA00CAOP | MFCD03421417
21218-94-0
21218-94-0
4-Phenoxy-benzoic acid methyl ester
AA00CB2F | MFCD00446993
25518-54-1
25518-54-1
(3R)-3-dodecanoyloxy-4-trimethylammonio-butanoate
AA00CD83 | MFCD01674830
Submit
© 2017 AA BLOCKS, INC. All rights reserved.